Leaflet TEVETEN PLUS 600mg / 12.5mg film-coated tablets
Indicated for: hypertension
Route of administration: oral
Substance: eprosartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)
ATC: C09DA02 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)
Dose adjustment may be needed in kidney disease.
Do not use this medicine during pregnancy.
Avoid excessive exposure to sunlight or UV radiation.
May lower blood pressure and increase the risk of falls.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
Eprosartan and hydrochlorothiazide are a combination of medications used to treat high blood pressure. Eprosartan works by relaxing blood vessels, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.
The combination is administered orally as tablets, once daily, according to the doctor's instructions. The dose is adjusted depending on the patient's response to treatment and any side effects.
Side effects may include dizziness, fatigue, digestive disorders, low potassium levels, or, rarely, allergic reactions. Monitoring blood pressure and electrolytes is recommended throughout the treatment.
The combination of eprosartan and hydrochlorothiazide is effective for controlling blood pressure, especially in patients who do not respond adequately to monotherapy.
General data about TEVETEN PLUS 600mg / 12.5mg
- Substance: eprosartan + hydrochlorothiazide
- Date of latest medicines list: 01-07-2013
- Product code: W43497003
- Concentration: 600mg / 12.5mg
- Pharmaceutical form: film-coated tablets
- Quantity: 56
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.